INDIVIOR INC.

Indivior Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in controlled substances and drug-device combination products. Their technical capabilities include the formulation, production, and regulatory-compliant scaling of specialty medications, particularly those requiring strict chain-of-custody controls, such as opioid dependence treatments and intranasal naloxone derivatives. The company demonstrates proficiency in navigating FDA regulatory pathways for complex drug delivery systems and maintaining GMP standards for federal supply chains. Their ability to deliver precision-manufactured pharmaceuticals under controlled conditions distinguishes them in high-integrity government procurement environments. Indivior has established consistent relationships with the Department of Justice, supplying controlled medications for correctional and law enforcement health programs, and with the Department of Health and Human Services, providing innovative drug-device combination products for overdose reversal. They also support the Department of Veterans Affairs through long-term pharmaceutical supply agreements for hematological and specialty drug categories, indicating a track record of reliability in mission-critical, high-volume dispensing environments. The contractor’s primary industry focus is NAICS 325412—pharmaceutical preparation manufacturing—where they operate at the intersection of specialty pharmacology and federal procurement. Their vertical specialization lies in controlled substance manufacturing and combination products requiring co-validated drug and delivery mechanisms, positioning them as a niche supplier for agencies requiring secure, compliant, and clinically validated pharmaceutical solutions. Indivior Inc. is a privately held entity headquartered in North Chesterfield, Virginia, with no public certifications on record. While not formally designated under federal small business programs, their geographic presence and manufacturing infrastructure support direct fulfillment for federal agencies across the U.S. healthcare and public safety sectors. Their operational model emphasizes regulatory adherence, supply chain integrity, and scalable production for government-mandated pharmaceutical needs.